GRAZAX(R) Approved in Europe - Good News for the Millions of Grass Allergy Sufferers in Europe.

PR Newswire Europe, September, 2006

HEyRSHOLM, Denmark, September 25 /PRNewswire/ --

- Authorities in 27 European Countries Have Now Approved ALK-Abello's Tablet-Based Vaccine Against Grass Pollen Allergy, GRAZAX(R)- the First Allergy Tablet to Address the Underlying Cause Of the Disease. ALK-Abello Expects to Launch the Innovative and Convenient Treatment on the First European Markets by the End of 2006, Ahead of the 2007 Pollen Season.

ALK-Abello today completed the European Mutual Recognition Procedure for GRAZAX(R), the company's tablet-based vaccine against grass pollen allergy, and authorities in 27 European countries have now approved the tablet treatment[1].

"We are very pleased to complete the European Mutual Recognition Procedure with such a positive result. This is a...